Standard
Cetilistat (ATL-962), a novel lipase inhibitor : a 12-week randomized, placebo-controlled study of weight reduction in obese patients. / Koppelman, P.; Bryson, A.; Hickling, R.; Rissanen, A.; Rossner, S.; Toubro, Søren; Valensi, P.
I:
International Journal of Obesity, Bind 31, Nr. 3, 2007, s. 494-499.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Koppelman, P, Bryson, A, Hickling, R, Rissanen, A, Rossner, S, Toubro, S & Valensi, P 2007, '
Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients',
International Journal of Obesity, bind 31, nr. 3, s. 494-499.
https://doi.org/10.1038/sj.ijo.0803446APA
Koppelman, P., Bryson, A., Hickling, R., Rissanen, A., Rossner, S., Toubro, S., & Valensi, P. (2007).
Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients.
International Journal of Obesity,
31(3), 494-499.
https://doi.org/10.1038/sj.ijo.0803446Vancouver
Koppelman P, Bryson A, Hickling R, Rissanen A, Rossner S, Toubro S o.a.
Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients.
International Journal of Obesity. 2007;31(3):494-499.
https://doi.org/10.1038/sj.ijo.0803446Author
Koppelman, P. ; Bryson, A. ; Hickling, R. ; Rissanen, A. ; Rossner, S. ; Toubro, Søren ; Valensi, P. / Cetilistat (ATL-962), a novel lipase inhibitor : a 12-week randomized, placebo-controlled study of weight reduction in obese patients. I: International Journal of Obesity. 2007 ; Bind 31, Nr. 3. s. 494-499.
Bibtex
@article{34703880a1c211ddb6ae000ea68e967b,
title = "Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients",
keywords = "Former LIFE faculty, ATL-962",
author = "P. Koppelman and A. Bryson and R. Hickling and A. Rissanen and S. Rossner and S{\o}ren Toubro and P. Valensi",
year = "2007",
doi = "10.1038/sj.ijo.0803446",
language = "English",
volume = "31",
pages = "494--499",
journal = "International Journal of Obesity",
issn = "0307-0565",
publisher = "nature publishing group",
number = "3",
}
RIS
TY - JOUR
T1 - Cetilistat (ATL-962), a novel lipase inhibitor
T2 - a 12-week randomized, placebo-controlled study of weight reduction in obese patients
AU - Koppelman, P.
AU - Bryson, A.
AU - Hickling, R.
AU - Rissanen, A.
AU - Rossner, S.
AU - Toubro, Søren
AU - Valensi, P.
PY - 2007
Y1 - 2007
KW - Former LIFE faculty
KW - ATL-962
U2 - 10.1038/sj.ijo.0803446
DO - 10.1038/sj.ijo.0803446
M3 - Journal article
C2 - 16953261
VL - 31
SP - 494
EP - 499
JO - International Journal of Obesity
JF - International Journal of Obesity
SN - 0307-0565
IS - 3
ER -
